Evaluation of the immunogenicity and safety of Brucella melitensis B115 vaccination in pregnant sheep

Vaccine

Volumn 32, Issue 16, 2014, Pages 1877-1881

  Pérez Sancho, Marta ^a   Adone, Rosanna ^b   García Seco, Teresa ^a   Tarantino, Michaela ^b   Diez Guerrier, Alberto ^a   Drumo, Rosanna ^b   Francia, Massimiliano ^b   Domínguez, Lucas ^a   Pasquali, Paolo ^b   Álvarez, Julio ^a,c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

Author keywords

B115 strain; Brucella melitensis; Pregnancy; Safety; Sheep; Vaccination

Indexed keywords

ABORTIVE AGENT; BRUCELLA VACCINE; CROSS REACTING ANTIBODY; ROSE BENGAL;

ABORTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BOVIDS; BRUCELLA MELITENSIS; BRUCELLOSIS; COMPLEMENT FIXATION TEST; CONTROLLED STUDY; DIAGNOSTIC TEST; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; EWE; FEMALE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INOCULATION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SEROLOGY; SHEEP; VACCINATION;

B115 STRAIN; BRUCELLA MELITENSIS; PREGNANCY; SAFETY; SHEEP; VACCINATION;

ABORTION, VETERINARY; ANIMALS; BRUCELLA MELITENSIS; BRUCELLA VACCINE; BRUCELLOSIS; FEMALE; IMMUNITY, CELLULAR; PREGNANCY; PREGNANCY, ANIMAL; SHEEP; SHEEP DISEASES; SHEEP, DOMESTIC; VACCINATION;

EID: 84895873568     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.070     Document Type: Article

References (33)

1. Corbel M.J. Brucellosis: an overview. Emerg Infect Dis 1997, 3(2):213-221.
2. FAO Brucella melitensis in Eurasia and the Middle East. FAO Animal Production and Health Proceedings 10 2009.
3. Pappas G., Akritidis N., Bosilkovski M., Tsianos E. Brucellosis. N Engl J Med 2005, 352(22):2325-2336.
4. Herzberg M., Elberg S.S. Immunization against Brucella infection. I. Isolation and characterization of a streptomycin-dependent mutant. J Bacteriol 1953, 66(5):585-599.
5. Alton G.G., Elberg S.S. Rev. 1 Brucella melitensis vaccine. A review of ten years of study. Vet Bull 1967, 37(11):793-800.
6. Banai M. Control of small ruminant brucellosis by use of Brucella melitensis Rev.1 vaccine: laboratory aspects and field observations. Vet Microbiol 2002, 90(1-4):497-519.
7. Blasco J.M. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats. Prev Vet Med 1997, 31(3-4):275-283.
8. Olsen S.C. Recent developments in livestock and wildlife brucellosis vaccination. Rev Sci Tech 2013, 32(1):207-217.
9. Jimenez de Bagues M.P., Marin C.M., Barberan M., Blasco J.M. Responses of ewes to B. melitensis Rev1 vaccine administered by subcutaneous or conjunctival routes at different stages of pregnancy. Ann Rech Vet 1989, 20(2):205-213.
10. Blasco J.M., Diaz R. Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet 1993, 342(8874):805.
11. Fensterbank R., Pardon P., Marly J. Comparison between subcutaneous and conjunctival route of vaccination with Rev. 1 strain against Brucella melitensis infection in ewes. Ann Rech Vet 1982, 13(4):295-301.
12. Martins H., Garin-Bastuji B., Lima F., Flor L., Pina F.A., Boinas F. Eradication of bovine brucellosis in the Azores, Portugal - outcome of a 5-year programme (2002-2007) based on test-and-slaughter and RB51 vaccination. Prev Vet Med 2009, 90(1-2):80-89.
13. Samartino L.E. Brucellosis in Argentina. Vet Microbiol 2002, 90(1-4):71-80.
14. Sanz C., Saez J.L., Alvarez J., Cortes M., Pereira G., Reyes A., et al. Mass vaccination as a complementary tool in the control of a severe outbreak of bovine brucellosis due to Brucella abortus in Extremadura, Spain. Prev Vet Med 2010, 97(2):119-125.
15. el Idrissi A.H., Benkirane A., el M.M., Bouslikhane M., Berrada J., Zerouali A. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Rev Sci Tech 2001, 20(3):741-747.
16. Jones L.M., Diaz R., Taylor A.G. Characterization of allergens prepared from smooth and rough strains of Brucella melitensis. Br J Exp Pathol 1973, 54(5):492-508.
17. Adone R., Francia M., Ciuchini F. Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections. Vaccine 2008, 26(38):4913-4917.
18. Adone R., Francia M., Pistoia C., Pesciaroli M., Pasquali P. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections. Vaccine 2011, 29(14):2523-2529.
19. Morgan W.J., Littlejohn A.I., Mackinnon D.J., Lawson J.R. The degree of protection given by living vaccines against experimental infection with Brucella melitensis in goats. Bull World Health Organ 1966, 34(1):33-40.
20. Alton G.G., Jones L.M., Angus R.D., Verger J.M. Techniques for the brucellosis laboratory 1988, INRA Publications, Paris, France.
21. Adone R., Francia M., Ciuchini F. Brucella melitensis B115-based complement fixation test to detect antibodies induced by Brucella rough strains. J Appl Microbiol 2008, 105(2):567-574.
22. Weynants V., Godfroid J., Limbourg B., Saegerman C., Letesson J.J. Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production. J Clin Microbiol 1995, 33(3):706-712.
23. OIE Bovine Brucellosis Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2009, [chapter 2.4.3].
24. Hinic V., Brodard I., Thomann A., Cvetnic Z., Makaya P.V., Frey J., et al. Novel identification and differentiation of Brucella melitensis, B., abortus, B., suis, B., ovis, B. canis, and B. neotomae suitable for both conventional and real-time PCR systems. J Microbiol Methods 2008, 75(2):375-378.
25. Le Fleche P., Jacques I., Grayon M., Al D.S., Bouchon P., Denoeud F., et al. Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay. BMC Microbiol 2006, 6:9.
26. Abramson J.H. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004, 1(1):6.
27. Zundel E., Verger J.M., Grayon M., Michel R. Conjunctival vaccination of pregnant ewes and goats with Brucella melitensis Rev. 1 vaccine: safety and serological responses. Ann Rech Vet 1992, 23(2):177-188.
28. Ebrahimi M., Nejad R.B., Alamian S., Mokhberalsafa L., Abedini F., Ghaderi R., et al. Safety and efficacy of reduced doses of Brucella melitensis strain Rev. 1 vaccine in pregnant Iranian fat-tailed ewes. Vet Ital 2012, 48(4):405-412.
29. Duran-Ferrer M., Leon L., Nielsen K., Caporale V., Mendoza J., Osuna A., et al. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis. Vet Microbiol 2004, 100(3-4):219-231.
30. Jacques I., Verger J.M., Laroucau K., Grayon M., Vizcaino N., Peix A., et al. Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep. Vaccine 2007, 25(5):794-805.
31. Adone R., Muscillo M., La R.G., Francia M., Tarantino M. Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18. PLoS ONE 2011, 6(10):e24073.
32. Cloeckaert A., Zygmunt M.S., Nicolle J.C., Dubray G., Limet J.N. O-chain expression in the rough Brucella melitensis strain B115: induction of O-polysaccharide-specific monoclonal antibodies and intracellular localization demonstrated by immunoelectron microscopy. J Gen Microbiol 1992, 138(6):1211-1219.
33. Bercovich Z., Dekker T., Eger A., Haagsma J. A comparison of the potency of several Brucella allergens used to detect brucellosis in cattle. Vet Res Commun 1996, 20(2):141-151.